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Abstract 
Even in cells which are resistant to the differentiating  effects of vitamin D, the activated vitamin D 
receptor (VDR) can down regulate the mitochondrial respiratory chain and sustain cell growth 
through enhancing the activity of biosynthetic pathways. The aim of this study was to investigate 
whether vitamin D is effective also in modulating mitochondria and biosynthetic metabolism of 
differentiating cells. We compared the effect of vitamin D on two cellular models: the primary 
human keratinocytes, differentiating and sensitive to the genomic action of VDR, and the human 
keratinocyte cell line HaCaT, characterized by a rapid growth and resistance to vitamin D. We 
analysed the nuclear translocation and features of VDR, the effects of vitamin D on mitochondrial 
transcription and the consequences on lipid biosynthetic fate. We found that the negative 
modulation of respiratory chain is a general mechanism of action of vitamin D, but at high doses the 
HaCaT cells became resistant to mitochondrial effects by upregulating the catabolic enzyme CYP24 
hydroxylase. In differentiating keratinocytes vitamin D treatment promoted intracellular lipid 
deposition, likewise the inhibitor of respiratory chain stigmatellin, whereas in proliferating HaCaT 
this biosynthetic pathway was not inducible by the hormone. By linking the results on respiratory 
chain and lipid accumulation we conclude that vitamin D, by suppressing respiratory chain 
transcription in all keratinocytes, is able to support both proliferation and the specialized 
metabolism of differentiating cells. Through mitochondrial control vitamin D can have an essential 
role in all the metabolic phenotypes occurring in healthy and diseased skin. 
 
 
 
Key words:  vitamin D receptor, keratinocyte, mitochondria, respiratory chain, lipid deposition. 
 
4 
 
Introduction 
Vitamin D (1,25(OH)2D3) exerts its pleiotropic effects through a genomic and non-genomic 
signaling mediated by its receptor VDR. In genomic modality VDR operates as a transcription 
factor, migrating into the nuclear compartment upon ligand binding and together with its binding 
partner RXR it recruits coactivators or corepressors to enhance or repress transcription.  The non-
genomic activity of VDR, on the other hand, occurs at plasmamembrane sites, where VDR 
modulates calcium fluxes (1,2). Recently our work has demonstrated a third novel mechanism of 
action of VDR that takes place in mitochondria (3). In fact we have shown that the receptor acts as 
modulator of mitochondrial activity and consequently as facilitator of the metabolic switch essential 
for cancer cell proliferation. 
Healthy differentiated cells are responsive to the differentiating properties of vitamin D. The skin is 
one of the tissues most dependent on vitamin D for regular differentiation, integrity and its 
physiological properties as a barrier. The skin is capable of vitamin D synthesis and activation, 
express the VDR and responds to VDR activation by induction or repression of a multitude of 
genes, demonstrating therefore an autocrine/paracrine regulation by the hormone. Epidermal 
keratinocytes undergo a complex program of differentiation giving rise to the different cell layers 
and the barrier function of the skin (4,5). When the balance between the proliferating reservoir and 
the fully differentiated epidermal layers is perturbed, a skin disease can arise, and vitamin D has 
demonstrated its efficacy in restoring epidermal homeostasis (6). Investigation of permeability and 
activity of vitamin D analogues in human skin has been facilitated by the recent generation of a new 
animal model with an engineered bioluminescent readout (7). 
The nuclear effects of VDR in keratinocytes have been extensively investigated, as well as the 
important modulation of calcium homeostasis exerted by VDR in these cells. The sequential role of 
VDR in regulating firstly basal cell proliferation and then the differentiated function in the upper 
layers of the epidermis is attributed at least in part to the different coregulators that modulate its 
genomic actions. The major coactivator complexes regulating VDR in the keratinocyte are 
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distinctly expressed during differentiation (8-10). On the contrary, several cancer cells are 
insensitive to the differentiating and antiproliferative action of vitamin D (11-15). We have 
demonstrated that in HaCaT cells resistant to vitamin D the mitochondrial effects of VDR facilitate 
cell growth (3). To date, nothing is known about the effects of VDR on mitochondrial activity of 
differentiated cells that are normally responsive to the genomic signaling of the receptor. 
The aim of this work was to study the effects of vitamin D on mitochondrial transcription of 
differentiating cells, and to investigate the impact on cellular metabolism. In order to understand the 
different results of VDR activity on differentiating and proliferating skin cells, we compared the 
effect of vitamin D on two cellular models: the primary human keratinocytes, which are 
differentiating and sensitive to the genomic action of the hormone, and the human keratinocyte cell 
line HaCaT, which is characterized by a rapid growth and resistance to the antiproliferative 
properties of vitamin D. We analysed the nuclear translocation and features of VDR, the effects of 
vitamin D on mitochondrial and nuclear transcription of COXII, COXIV and CYP24A1 genes, and 
also on lipid deposition in differentiating primary keratinocytes and immortalised HaCaT cells. We 
describe a common mechanism of action through which vitamin D modulates mitochondrial 
activity, but we demonstrate a different impact on cellular metabolism, which depends on the 
proliferative or differentiated status of the cell. 
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Methods 
Cell culture and treatment 
The immortalized human epidermal keratinocyte cell line (HaCaT) was purchased from American 
Type Culture Collection (ATCC), USA, and were cultured in Dulbecco's modified Eagle's medium 
(DMEM) that had been supplemented with 10% fetal bovine serum and 1% antibiotics [penicillin-
streptomycin (Sigma-Aldrich)] at 37°C in a humidified atmosphere containing 5% CO2. 
Differentiating and quiescent primary keratinocytes were obtained from Banca della Cute, AOU 
Città della Salute e della Scienza, Torino, Italy, and were prepared as previously reported (16). Primary 
cultures were used at confluency in early passages. When treated, the cells were maintained in 
DMEM that had been supplemented with 1% fetal bovine serum and were incubated for up to 48 
hours with 10 nM or 100 nM 1,25(OH)2D3 or 10 nM stigmatellin (Sigma-Aldrich). 
 
Extract preparation and western blotting analyses 
Subcellular fractionation and western blotting analyses were carried out as previously described 
(17). Lysates were subjected to differential centrifugation to isolate the nuclear and mitochondrial 
fraction. Proteins were extracted from nuclei and mitochondria by incubation in boiling sample 
buffer followed by sonication. In HaCaT cell lysates, nuclear fractionation was achieved by 
incubation of nuclei in buffer C (420 mM NaCl, 1 mM EDTA, 20 mM HEPES pH 7.9, 25% 
glycerol, 1 mM protease inhibitors, 1 mM PMSF) for 20 min at 4 °C with agitation. After 
centrifugation for 15 min at 16,000 × g at 4 °C, supernatants (corresponding to nucleosol) were 
separated from nuclear pellets, which were resuspended in boiling sample buffer followed by 
sonication. Thirty µg of each fraction were separated using 10% SDS-PAGE and analysed by 
western blotting. Mouse anti-VDR (sc-13133) and rabbit antibody anti-PARP (sc-7150) were from 
Santa Cruz, CA, USA. 
 
DNase treatment 
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Pelleted nuclei were washed in isotonic buffer (10 mm Tris HCl, pH 7.4, 150 mm NaCl) and then 
incubated for 20 min at 37 °C in 0.5 ml of digestion buffer containing 10 mm Tris HCl, pH 7.4, 10 
mm NaCl, 5 mm MgCl2, 0.2 mm PMSF, and 200 units of DNase I (Sigma) (18). Nuclei were 
pelleted at 14,000 rpm, and the supernatant, containing the DNA-released material, was taken. 
Nuclear pellet was resuspended in boiling sample buffer followed by sonication. The protein 
content of the nuclear pellet fraction was quantified and 50 µg were separated using 10% SDS-
PAGE and analysed by western blotting. 
 
RNA extraction and real-time PCR 
RNA was extracted using TRIzol (Invitrogen) and 1 μg of total RNA that had been treated with 
DNase (Roche) was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad) according 
to the manufacturer’s recommended protocol. Real-time PCR was performed using iQ SYBR Green 
(Bio-Rad) with the following primers:  
COXII, fwd 5′-CGACTACGGCGGACTAATCT-3′, rev 5′-TCGATTGTCAACGTCAAGGA-3′; 
COXIV, fwd 5′-CGAGCAATTTCCACCTCTGT-3′, rev 5′-GGTCAGCCGATCCATATAA-3′;  
CYP24, fwd 5’- CGTTTGGACGATGATGGTCAC, rev 5’-TTTCTTGAAGCCGATTCTGGTG; 
β-actin, fwd 5′-CATGTACGTTGCTATCCAGGC-3′, rev 5′-CTCCTTAATGTCACGCACGAT-3′  
Beta-actin was used as an internal control. The real-time PCR parameters were as follows: Cycle 1, 
50°C for 2 minutes; cycle 2, 95°C for 10 minutes, followed by 45 cycles at 95°C for 15 seconds and 
then 60°C for 1 minute. The 2-ΔΔCT method was used to analyse the data. 
 
Oil Red O staining 
To assay lipid deposition after 48 hours of treatment with 10 nM stigmatellin (Sigma-Aldrich) or 10 
nM vitamin D or just regular medium, cells were stained with Oil Red O (ORO, Sigma-Aldrich) 
according to Kim et al. (19). Briefly, cells were fixed with 4% paraformaldehyde overnight and 
washed with 60% isopropanol. After drying cells, 0.21% ORO in 60% isopropanol was applied to 
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the cells for 10 minutes followed by 4 times washing with distilled water. Stained ORO was 
extracted with 100% isopropanol and absorbance was measured at 520 nm. Pictures were taken 
before extraction. 
 
Bands quantification and statistical analysis 
Bands from protein electrophoresis were quantified by scanning digital densitometry using an 
ImageJ software analysis (ImageJ version 1.29, Sun Microsystems Inc., Palo Alto, CA). Statistical 
analysis of data was performed using ANOVA test with Tukey's post-hoc correction. p values <0.05 
were considered significant. All data were expressed as mean ± S.D 
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Results 
Differentiating keratinocytes show ligand-dependent nuclear translocation of VDR, 
whereas HaCaT cells are insensitive to vitamin D treatment 
In order to verify that our in vitro model of primary human keratinocytes corresponded to a 
differentiating tissue responsive to the nuclear effects of vitamin D, we assessed VDR translocation 
into nuclear compartment, driven by ligand binding and necessary for the transcriptional activity of 
the receptor. At both the concentrations of vitamin D tested (10 and 100 nM), we were able to 
detect a strong nuclear translocation of VDR (Fig. 1A), with small differences in amplitude 
depending on the culture analysed. Although different primary cell preparations responded slightly 
differently to stimulation, the nuclear levels of VDR were consistently higher in treated cells 
compared with control (Fig. 1B). On the contrary, in our previous work we have reported that 
HaCaT cells display high levels of nuclear VDR but have lost the modulation of the nuclear 
shuttling of the receptor, and the absence of ligand-dependent nuclear translocation is associated 
with the loss of the antiproliferative effects of vitamin D (3,17). In this study HaCaT cells 
represented therefore a model of proliferating human keratinocytes resistant to the differentiating 
properties of vitamin D. In order to better characterize the abundant nuclear VDR of HaCaT cells, 
the nuclear extracts were further processed and we obtained the soluble fraction (nucleosol) and the 
particulate fraction (nuclear pellet, comprehensive of chromatin, associated proteins and the 
components of nuclear envelope). The analysis of nucleosol and nuclear pellet of treated and 
control cells confirmed that VDR levels were not modulated by ligand binding, and most 
interestingly we detected a nuclear VDR present only in the particulate fraction (Fig. 1C). This 
partition is not always typical of nuclear factors, for example we found that the levels of the nuclear 
enzyme poly (ADP-ribose) polymerase (PARP) were distributed quite in the opposite way between 
the two fractions. To verify whether the receptor was retained in the nuclear particulate fraction as a 
result of strong binding to chromatin, we treated the nuclear pellets with DNase, thereby digesting 
the chromatin and releasing any bound protein. After this treatment VDR was lost from pellet, as 
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well as PARP, which is notoriously an enzyme working on DNA (Fig 1D) (20). The results of these 
experiments demonstrated that HaCaT cells possess a nuclear VDR, tightly docked to DNA, which 
upon ligand stimulation does not increase its already robust nuclear presence. 
 
Vitamin D treatment inhibits the transcription of the respiratory chain 
In our previous work, we demonstrated that in HaCaT cells VDR exerted profound effects on 
mitochondrial activity by downregulating the transcription of respiratory chain subunits (3). Also in 
primary keratinocytes VDR is localized in the mitochondrial compartment, as shown by western 
blotting analysis of mitochondrial extracts (Fig. S1). In this study we tested the effects of two 
concentrations of vitamin D on the transcription rate of the two considered cellular models and we 
found interesting differences. We treated the cells with 10 and 100 nM of vitamin D up to 48 hours 
and by real time PCR analysis we confirmed that VDR was able to downregulate the transcription 
of both subunit II and IV of complex IV ( cytochrome c oxidase COX II and IV), whose transcripts 
are of mitochondrial (the former) and nuclear (the latter) origin. Both nuclear and mitochondrial-
encoded proteins are required for the formation of active respiratory complexes; in our assay we 
evaluated COX II as a marker of mitochondrial transcription activity and COX IV as a marker of 
the nuclear contribution to respiratory chain modulation. Vitamin D at the concentration of 10 nM 
was effective in restraining transcription of COX II and IV both in the differentiating keratinocytes 
and in proliferating HaCaT (Fig. 2A and 2B upper panels). However, the higher dose of 100 nM, 
which was still effective in differentiating keratinocyte (Fig. 2A middle panel), in HaCaT was able 
to downregulate transcription only for the first 24 hours, and the effect was reverted in the 
following 24 hours (Fig. 2B middle panel). HaCaT cells demonstrated therefore a delayed 
resistance to the mitochondrial effects of vitamin D. It has been reported that vitamin D controls its 
own activity by transcriptional induction of the catabolic enzyme CYP24A1 (21). The increased 
activity of this enzyme has been deemed responsible also for the resistance to vitamin D detected in 
several cancer cells (22,23). We measured the levels of CYP24 transcript in both cellular systems, 
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and we found that in HaCaT cells CYP24 was indeed strongly potentiated in the same experimental 
conditions that reversed the effect of vitamin D (100 nM at 48 hours, Fig. 2B lower panel). In 
differentiating keratinocytes a strong induction was not evident, since CYP24 did not reached the 
levels seen in HaCaT at 48 hours (Fig. 2A lower panel). The analysis of the effects exerted by 
vitamin D on mitochondria demonstrated a common mechanism of action in both differentiating 
and proliferating keratinocytes, but proliferating HaCaT cells were resistant to 1,25(OH)2D3 
activity, at least in part due to the high induction of CYP24A1 catabolic activity 
 
Vitamin D promotes lipid accumulation in differentiating keratinocytes but not in 
proliferating HaCaT cells 
The finding that in keratinocytes, whether they be differentiating or proliferating, vitamin D 
hampers mitochondrial transcription prompted us to investigate the impact of a reduced activity of 
respiratory chain on metabolism, which must be different in order to sustain a differentiation 
cellular program or a proliferative state. In our previous work (3) we have demonstrated that in 
HaCaT cells VDR acts as a promoter of acetyl-CoA utilization outside of the mitochondria in the 
mevalonate biosynthetic pathway. In proliferating cells the most important final product of the 
biosynthetic fate of acetyl-CoA is cholesterol, essential for duplication processes. In this study we 
considered which biosynthetic pathway would mostly benefit from an increased availability of 
acetyl-CoA in differentiated cells. The most superficial terminally differentiated layers of epidermis 
produce lipids that are secreted into the extracellular space where they contribute to the formation 
of the hydrophobic lipid envelope responsible for the barrier properties of the skin. Therefore we 
sought to investigate whether differentiating keratinocytes could respond to vitamin D by enhancing 
intracellular lipid deposition. The same analysis was carried out in HaCaT cells, as it had never 
been performed before. We treated both cellular models for 48 hours at low vitamin D 
concentration (10 nM) to avoid the resistant phenotype observed in HaCaT cells, and we detected 
the intracellular lipid deposition by Oil-red O staining. We also treated the cells with an inhibitor of 
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the respiratory chain, stigmatellin, which with a different mechanism of action should affect the 
respiratory chain even more than VDR, therefore it should have a similar impact on metabolism. 
Actually, the two treatments produced equivalent results on differentiating keratinocytes, promoting 
a strikingly evident accumulation of lipids (Fig. 3A). On the contrary, HaCaT cells treated with 
vitamin D did not show any difference from control, while stigmatellin was still able to cause a fair 
lipid deposition (Fig. 3A). The results of different experiments were quantified and averaged (Fig. 
3B), and we were able to demonstrate that vitamin D treatment leads to intracellular lipid 
accumulation only in differentiating keratinocytes, whereas in proliferating HaCaT this biosynthetic 
pathway is not inducible by the hormone. 
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Discussion 
To date, the effects of vitamin D activity on mitochondria of differentiated cells were not known, 
therefore in this study we decided to compare the response to vitamin D in two different cellular 
phenotypes: proliferating and differentiating human keratinocytes. As validation of our cellular 
models, we found that the differentiating keratinocytes responded to vitamin D by activating the 
classical pathway of nuclear translocation of VDR, whereas HaCaT, previously characterized as 
vitamin D-resistant cells (3), displayed a vitamin D-independent nuclear expression of the receptor. 
Interestingly, our analysis revealed that VDR was tightly bound to chromatin, again independently 
from ligand stimulation. The binding of VDR to VDRE regions and its ability to enhance or silence 
gene transcription is the result of complex interactions with dimerization partners, coactivators and 
corepressors, as extensively described by the work of Bikle and coll. (8,9) and Campbell and coll. 
(24,25). Transformed keratinocytes are less responsive to the antiproliferative actions of 
1,25(OH)2D3 than are normal keratinocytes despite having normal levels of VDR (11,12,26). This 
altered response has been ascribed to the perturbation of nuclear signaling of the hormone (8,24). 
Deregulation of corepressor binding could be the main mechanism of resistance to vitamin D. In 
transformed cells the normal replacement operated by vitamin D, that dissociates corepressor 
hairless (Hr) and recruits coactivators on VDR (27), could be defective and the corepressor could 
bind a silent VDR to chromatin. Actually, Hr has been found to repress VDR transactivation in 
HaCaT cells (28,29). Other studies have given evidences of an epigenetic resistance in cancer that 
often involves elevated expression of the corepressor NCoR2/SMRT (24,25). Thus our novel 
finding of a VDR permanently bound to DNA in HaCaT cells is not surprising, and it is in 
agreement with the resistance of these cells to the antiproliferative properties of vitamin D. 
The negative modulation of the respiratory chain transcription and activity exerted by VDR in 
HaCaT cells had been described in our previous work (3), and this mechanism of action found a 
confirmation in the present study on differentiating keratinocytes. VDR is present in the 
mitochondrial compartment of primary keratinocytes, it is therefore reasonable to hypothesize that 
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also in these cells vitamin D exerts a combined mitochondrial and nuclear transcriptional control on 
respiratory chain, as suggested by the investigation of VDR in HaCaT (3). Moreover, by testing 
different concentrations of vitamin D, in this study we discovered that in HaCaT high doses of the 
ligand induce insensitivity to the mitochondrial effects of the hormone. This mitochondrial 
resistance is acquired upon potent induction of CYP24A1, the catabolic enzyme target of VDR that 
turns off a massive signaling of vitamin D. Elevated levels of CYP24 are common in cancer (30-
32), thus CYP24 activity has been identified as one of the causes of resistance to vitamin D, 
although to date the role of CYP24 has been described in genomic resistance only.  Vitamin D can 
induce 24-hydroxylase expression in transformed lines as well as in normal keratinocytes (11,33), 
even when it cannot induce enzymes required for differentiation. The difference is due to the failure 
of transformed keratinocytes to switch coactivator complexes; this unbalance disturbs the readout of 
the genes required for differentiation whereas it facilitates CYP24 transcription. Our observations 
on CYP24 induction are therefore reasonable and in agreement with other reports, however we 
describe for the first time the impact of this mechanism of resistance on mitochondrial activity. 
The other major finding of this study was the analysis of lipid production. In our previous work (3) 
we demonstrated that the negative modulation of respiratory chain activity promoted the diversion 
of acetyl-CoA from the energetic catabolism toward the biosynthetic pathways. In proliferating 
HaCaT cholesterol was one of the main products of the metabolic shift promoted by VDR. In this 
study, we found that the same mitochondrial modulation occurred in differentiating keratinocytes, 
but the metabolic switch triggered by vitamin D in these cells promoted lipid deposition. Lipid 
biosynthesis and secretion is a metabolic specialization of differentiated keratinocytes. Lipids are 
synthesized in the keratinocytes of the stratum granulosum, assembled within organelles named 
lamellar bodies (34) and then secreted and processed in the extracellular space, eventually forming 
the lamellar bilayers that mediate permeability barrier function (35). Stratum corneum contains 
large quantities of lipids, which are primarily comprised of mixtures of ceramides, cholesterol, and 
free fatty acid (36). The biosynthetic pathway of the most abundant lipids ceramides is tightly 
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controlled by VDR. In fact it has been demonstrated that VDR and SRC coactivators are required 
for the production of epidermal-specific glucosylceramide and subsequent barrier formation (37). 
Mice deficient in 25-hydroxylase, which is required for the formation of active 1,25(OH)2D3, have 
impaired barrier repair after acute disruption due to a decrease in lamellar body secretion (38). In 
our study we have confirmed in differentiating keratinocytes the important role of vitamin D in lipid 
accumulation and we have related the lipogenic effect with the downregulation of electron transport 
chain. The link is supported by the enhanced lipid biosynthesis observed after treatment of 
differentiating keratinocytes with stigmatellin, which inhibits the respiratory chain and increases 
lipid deposition. Proliferating HaCaT cells, on the other hand, do not respond to vitamin D-
dependent mitochondrial modulation by variation in lipid droplets content, in agreement with the 
previously demonstrated utilization of acetyl-CoA in cholesterol biosynthesis to sustain 
proliferation (3).  
From our data we concluded that the negative modulation of mitochondrial respiratory chain is a 
common mechanism of action of VDR, however the outcome of the consequent rerouting of 
intermediates is different depending on metabolic demands, as shown in Fig. 4. In differentiating 
keratinocytes VDR is able to trigger  the nuclear effects and the downregulation of electron 
transport chain. Spared acetyl-CoA is thus rewired toward the proper biosynthetic fate, represented 
mainly by lipid droplet deposition and secretion (upper model). In proliferating keratinocytes (and 
cancer cells) the negative modulation of respiratory activity is not associated with a differentiating 
action of vitamin D. Therefore the diversion of acetyl-CoA results in enhanced cholesterol 
biosynthesis, necessary to the proliferative state of the cell (lower model). 
The differential effects of vitamin D on differentiating and proliferating human keratinocytes 
described in this work lay the molecular basis that can help to understand the physiological role of 
vitamin D as regulator of both proliferation and differentiation processes present in healthy skin. In 
addition to nuclear dynamics controlled by coregulators (reviewed in (39)), our work highlights 
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how VDR can modulate mitochondrial and cellular metabolism to sustain the different cellular 
phenotypes composing the skin.  
Moreover, the data presented here shed light on the dual role given to VDR as tumor 
suppressor/facilitator, which could be particularly relevant in skin cancers. A recent epidemiologic 
study has reported a positive association between baseline vitamin D levels and basal cell 
carcinoma and melanoma incidence and a negative association with squamous cell carcinoma 
incidence (40). The results of our study, that highlight how vitamin D can support both 
differentiating and proliferating metabolism, would explain why vitamin D has been considered 
both a procarcinogenic and anticarcinogenic agent (41-46).  
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Figure legends 
Figure 1. Characterization of ligand-dependent nuclear localization of VDR in primary 
keratinocytes and HaCaT cells. (A) Primary keratinocytes responded to the 24 h treatment with 
vitamin D 10 nM (D10) or 100 nM (D100) by translocating VDR into nuclear compartment. Thirty 
g of nuclear proteins from untreated (control, C) or treated cells were analysed by western blotting 
for VDR. The blot is representative of three independent experiments, in which different primary 
cultures were used. (B) Bands from experiments based on three different cultures (named KER 119, 
120, 121) were quantified, normalized for loading as a ratio to PARP expression and data plotted on 
graph as percentage of control. (C) HaCaT cells showed basal levels of nuclear VDR which were 
not modulated by vitamin D treatment. Nuclear extracts from HaCaT cells were separated in 
nucleosol (N) and nuclear pellet (NP) fractions and 30 g of proteins from untreated or treated cells 
were analysed by western blotting for VDR. PARP expression was used as control of equal loading. 
(D) After DNase treatment of HaCaT nuclear extracts, proteins still present in nuclear pellet were 
analysed by western blotting for VDR and PARP. The blots are representative of three independent 
experiments. 
Figure 2. Vitamin D treatment inhibits the transcription of respiratory chain complexes. Primary 
keratinocytes (A) and HaCaT cells (B) were treated for 48 hours with vitamin D 10 nM (D10) and 
100 nM (D100). After 24 and 48 hours of treatment mRNAs were purified and assayed by real time 
PCR for COX II, COX IV and CYP24 transcript expression. The values plotted on the graphs 
represent the fold change in transcript expression in treated versus untreated cells and are displayed 
as the means ± SD of three independent experiments. * P<0.05 compared to the untreated cells. 
§
 
P<0.05 compared to D10 treated cells. 
Figure 3. Treatment with Vitamin D and with an inhibitor of respiratory chain activity induces 
intracellular lipid accumulation in primary keratinocytes but not in HaCaT cells. Primary 
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keratinocytes and HaCaT cells were treated for 48 hours with  10 nM stigmatellin or 10 nM vitamin 
D. Cells were stained with Oil red O and pictures were taken (A). The image is representative of a 
set of three independent experiments. Afterwards, staining was solubilized and quantified by 
spectrophotometer (B). Data represent the means ± SD of three independent experiments. * P<0.05 
compared to the untreated cells.  
Figure 4. A working model of the molecular mechanisms underlying VDR effects on metabolism 
of differentiating primary keratinocytes and proliferating HaCaT cells. Vitamin D through its 
receptor VDR exerts a general role as inhibitor of mitochondrial electron transport chain (ETC) and 
as facilitator of the diversion of mitochondrial acetyl-CoA toward biosynthetic pathways; the 
impact on metabolism depends on the differentiated or proliferative status of the cell. Upper panel: 
in differentiating keratinocytes vitamin D is effective in nuclear compartment as inducer of 
differentiation; this condition forces the utilization of acetyl-CoA into lipid biosynthesis and 
secretion. Lower panel: in proliferating keratinocytes nuclear resistance hampers differentiating 
effects of vitamin D; the unaltered proliferative status requires an enhanced biosynthesis of 
cholesterol, which is achieved by channeling acetyl-CoA into the cholesterol biosynthetic pathway 
that sustains proliferation. TCA cycle: tricarboxylic acid cycle; AS: ATP synthase. 
 
 
Supporting Information 
Additional supporting data may be found in the supplementary information of this article. 
 
Legend for supplemental illustration 
Figure S1. Mitochondrial localization of VDR in primary keratinocytes. Equal amounts of proteins 
from the mitochondrial extracts of HaCaT (H) and primary keratinocytes (K) were analysed by 
western blotting and VDR expression was detected in both cells. 
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